Several measures can be adopted to avoid and combat the flu. However, it is important to note that viruses, like influenza, frequently change its structure to evade the immune system, resulting in new ...

INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315 ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. The Big Pharma company discontinued the study testing intra ...

Use of a neoadjuvant checkpoint inhibitor enabled a high proportion of patients with early-stage mismatch repair-deficient (dMMR) solid tumors to avoid surgery and achieve organ preservation in a ...

Treatment with delgocitinib cream, a topical pan-Janus kinase inhibitor, resulted in a significant improvement in health-related quality of life in patients with moderate to severe chronic hand ...

In a recently published phase 2b extension study, adding narrow-band ultraviolet B (nbUVB) phototherapy to ritlecitinib, an oral Janus kinase (JAK) 3/tyrosine-protein kinase inhibitor, resulted in ...

A December analysis published in Science showed that a single mutation in the genes coding for the protein hemagglutinin in H5N1 bird flu virus in cows could be enough to change the virus ...